128 related articles for article (PubMed ID: 6175837)
1. Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade.
Bertel O; Bühler FR; Burkart F
J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S181-6. PubMed ID: 6175837
[TBL] [Abstract][Full Text] [Related]
2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
3. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
Bertel O; Burkart F; Bühler FR
Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
[TBL] [Abstract][Full Text] [Related]
4. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ibopamine plus prazosin in congestive heart failure.
Naidoo DP; Rocke A; Mitha AS
S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492
[TBL] [Abstract][Full Text] [Related]
6. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Stein L; Henry DP; Weinberger MH
Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
[TBL] [Abstract][Full Text] [Related]
7. Prazosin and congestive heart failure: short- and long-term therapy.
Rouleau JL; Warnica JW; Burgess JH
Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
9. The effects of bromocriptine in patients with congestive heart failure.
Francis GS; Parks R; Cohn JN
Am Heart J; 1983 Jul; 106(1 Pt 1):100-6. PubMed ID: 6346844
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure.
Kassis E; Amtorp O
Circulation; 1987 Jun; 75(6):1204-13. PubMed ID: 2882868
[TBL] [Abstract][Full Text] [Related]
11. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
Colucci WS
Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
[TBL] [Abstract][Full Text] [Related]
12. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
Petein M; Levine TB; Cohn JN
Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
[TBL] [Abstract][Full Text] [Related]
13. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
[TBL] [Abstract][Full Text] [Related]
14. Effects of bucindolol on neurohormonal activation in congestive heart failure.
Eichhorn EJ; McGhie AL; Bedotto JB; Corbett JR; Malloy CR; Hatfield BA; Deitchman D; Willard JE; Grayburn PA
Am J Cardiol; 1991 Jan; 67(1):67-73. PubMed ID: 1670902
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
Yui Y; Sakurai T; Nakajima H; Kawai C
Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282
[TBL] [Abstract][Full Text] [Related]
16. Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent.
Renard M; Walter M; Liebens I; Dresse A; Bernard R
Chest; 1988 Jun; 93(6):1159-64. PubMed ID: 3371093
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
19. [Alpha receptor blocking and cardial insufficiency].
Klein W
Wien Med Wochenschr; 1982; 132 Spec No():6-9. PubMed ID: 6123199
[TBL] [Abstract][Full Text] [Related]
20. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
